Year |
Citation |
Score |
2018 |
Gu X, Ebrahem Q, Mahfouz RZ, Hasipek M, Enane F, Radivoyevitch T, Rapin N, Przychodzen B, Hu Z, Balusu R, Cotta CV, Wald D, Argueta C, Landesman Y, Martelli MP, et al. Leukemogenic nucleophosmin mutation disrupts the transcription factor hub regulating granulo-monocytic fates. The Journal of Clinical Investigation. PMID 30015632 DOI: 10.1172/Jci97117 |
0.387 |
|
2017 |
Pelland K, Mathews S, Kamath A, Cohen P, Hudnall SD, Cotta CV, Xu ML. Dendritic Cell Markers and PD-L1 are Expressed in Mediastinal Gray Zone Lymphoma. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 29189264 DOI: 10.1097/Pai.0000000000000615 |
0.345 |
|
2017 |
Guo L, Wang Z, Anderson CM, Doolittle E, Kernag S, Cotta CV, Ondrejka SL, Ma XJ, Cook JR. Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 29052600 DOI: 10.1038/Modpathol.2017.142 |
0.307 |
|
2017 |
Kim HG, LeGrand J, Swindle CS, Nick HJ, Oster RA, Chen D, Purohit-Ghelani S, Cotta CV, Ko R, Gartland L, Reddy V, Hiebert SW, Friedman AD, Klug CA. The assembly competence domain is essential for inv(16)-associated acute myeloid leukemia. Leukemia. PMID 28751774 DOI: 10.1038/Leu.2017.236 |
0.693 |
|
2017 |
Sharma TL, Yeaney GA, Soltanzadeh P, Li Y, Cotta CV. Intravascular T-cell lymphoma: A rare, poorly characterized entity with cytotoxic phenotype. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 28317291 DOI: 10.1111/Neup.12376 |
0.371 |
|
2016 |
Vatolin S, Phillips JG, Jha BK, Govindgari S, Hu JC, Grabowski D, Parker Y, Lindner DJ, Zhong F, Distelhorst CW, Smith MR, Cotta C, Xu Y, Chilakala S, Kuang RR, et al. Novel protein disulfide isomerase inhibitor with anti-cancer activity in multiple myeloma. Cancer Research. PMID 27197150 DOI: 10.1158/0008-5472.Can-15-3099 |
0.344 |
|
2016 |
Turakhia SK, Murugesan G, Cotta CV, Theil KS. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations. Journal of Clinical Pathology. PMID 26754830 DOI: 10.1136/Jclinpath-2015-203498 |
0.339 |
|
2016 |
Gu X, Mahfouz RZ, Ebrahem Q, Enane F, Radivoyevitch T, Clemente MJ, Przychodzen BP, Hu Z, Balusu R, Cotta CV, Wald DN, Landesman Y, Martelli MP, Falini B, Maciejewski JP, et al. The Mechanism By Which Mutant Nucleophosmin (NPM1) Creates Leukemic Self-Renewal Is Readily Reversed Blood. 128: 444-444. DOI: 10.1182/Blood.V128.22.444.444 |
0.492 |
|
2015 |
Ruiz SJ, Cotta CV. Follicular helper T-cell lymphoma: A B-cell-rich variant of T-cell lymphoma Annals of Diagnostic Pathology. 19: 187-192. PMID 25913305 DOI: 10.1016/J.Anndiagpath.2015.03.008 |
0.408 |
|
2014 |
Cotta CV, Hsi ED. IgG4+ plasma cells in isolated reactive lymphadenopathy. American Journal of Clinical Pathology. 142: 432-4. PMID 25239407 DOI: 10.1309/Ajcpebysmjp0Omil |
0.304 |
|
2014 |
Turakhia SK, Hill BT, Dufresne SD, Nakashima MO, Cotta CV. Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics. American Journal of Clinical Pathology. 142: 339-46. PMID 25125624 DOI: 10.1309/Ajcpbwvhtf7Rrsa4 |
0.381 |
|
2014 |
Vatolin S, Phillips JG, Govindgari S, Grabowski D, Parker Y, Lindner D, Cotta C, Reu FJ. A Novel in Vitro Three Organ System Assay Identifies a Small Molecule Ubiquitin Analog with in Vivo Activity Against Myeloma Blood. 124: 2085-2085. DOI: 10.1182/Blood.V124.21.2085.2085 |
0.387 |
|
2013 |
Duong HK, Cotta CV. Favorable outcome of plasmablastic lymphoma expressing both immunoglobulin light chains arising in an immunocompetent man Journal of Hematopathology. 6: 93-97. DOI: 10.1007/S12308-012-0150-Z |
0.344 |
|
2012 |
Advani A, Cooper B, Sowunmi O, Elson P, Ali-Osman F, Park J, Rao A, Rizzieri DA, Wang ES, Cotta C, Sekeres MA, Kalaycio M, Sobecks R, Rouphail B, Maciejewski JP, et al. A Phase 2 Trial of Imatinib Mesylate As Maintenance Therapy for Patients with Newly Diagnosed C-Kit Positive Acute Myeloid Leukemia (AML) Blood. 120: 3597-3597. DOI: 10.1182/Blood.V120.21.3597.3597 |
0.301 |
|
2011 |
Cotta CV, Coleman JF, Li S, Hsi ED. Nodular lymphocyte predominant Hodgkin lymphoma and diffuse large B-cell lymphoma: a study of six cases concurrently involving the same site. Histopathology. 59: 1194-203. PMID 22175899 DOI: 10.1111/J.1365-2559.2011.04054.X |
0.333 |
|
2010 |
Advani AS, Tiu R, Saunthararajah Y, Maciejewski J, Copelan EA, Sobecks R, Sekeres MA, Bates J, Rush ML, Tripp B, Salvado A, Noon E, Howard M, Jin T, Hsi E, ... ... Cotta CV, et al. A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia. Leukemia Research. 34: 1622-6. PMID 20427086 DOI: 10.1016/J.Leukres.2010.03.021 |
0.326 |
|
2010 |
Lazaryan A, Lichtin AE, McCrae KR, Reed J, Dean R, Cotta C, Reu FJ. Bortezomib for ITP: First Report of Successful Treatment of Refractory ITP In a Patient with Otherwise Asymptomatic Monoclonal Gammopathy Blood. 116: 4667-4667. DOI: 10.1182/Blood.V116.21.4667.4667 |
0.326 |
|
2010 |
Shadman M, Gibson S, Cotta C, Saunthararajah Y, Hsi E, Copelan E, Kalaycio M, Sekeres MA, Sobecks R, Effinger M, Advani AS. Prognostic Significance of Histone (H4) Acetylation In Newly Diagnosed Acute Myeloid Leukemia (AML) Patients with Intermediate Risk Cytogenetics Blood. 116: 2736-2736. DOI: 10.1182/Blood.V116.21.2736.2736 |
0.315 |
|
2009 |
Drakos E, Rassidakis GZ, Leventaki V, Cotta CV, Vega F, Medeiros LJ. Nodular lymphocyte predominant Hodgkin lymphoma with clusters of LP Cells, acute inflammation, and fibrosis: a syncytial variant. The American Journal of Surgical Pathology. 33: 1725-31. PMID 19730363 DOI: 10.1097/Pas.0B013E3181B27765 |
0.371 |
|
2009 |
Shadman M, Gibson S, Cotta C, Hsi ED, Copelan E, Kalaycio M, Sekeres MA, Sobecks R, Saunthararajah Y, Effinger M, Advani A. Strong Histone (H4) Acetylation Is Independently Associated with Better Overall Survival in Newly Diagnosed Acute Myeloid Leukemia (AML). Blood. 114: 4681-4681. DOI: 10.1182/Blood.V114.22.4681.4681 |
0.318 |
|
2008 |
Cotta CV, Hsi ED. Pathobiology of mature T-cell lymphomas. Clinical Lymphoma & Myeloma. 8: S168-79. PMID 19073524 DOI: 10.3816/Clm.2008.S.013 |
0.382 |
|
2008 |
Cotta CV, Leventaki V, Atsaves V, Vidaki A, Schlette E, Jones D, Medeiros LJ, Rassidakis GZ. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer. 112: 552-61. PMID 18085637 DOI: 10.1002/cncr.23196 |
0.341 |
|
2008 |
Kim HG, Kojima K, Swindle CS, Cotta CV, Huo Y, Reddy V, Klug CA. FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia. Blood. 111: 1567-74. PMID 17967943 DOI: 10.1182/Blood-2006-06-030312 |
0.699 |
|
2007 |
Zhang Z, Swindle CS, Bates JT, Ko R, Cotta CV, Klug CA. Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood. 109: 2190-7. PMID 17110463 DOI: 10.1182/Blood-2005-01-031930 |
0.732 |
|
2006 |
Wang N, Kim HG, Cotta CV, Wan M, Tang Y, Klug CA, Cao X. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability. The Embo Journal. 25: 1469-80. PMID 16525506 DOI: 10.1038/Sj.Emboj.7601037 |
0.613 |
|
2004 |
Kim HG, de Guzman CG, Swindle CS, Cotta CV, Gartland L, Scott EW, Klug CA. The ETS family transcription factor PU.1 is necessary for the maintenance of fetal liver hematopoietic stem cells. Blood. 104: 3894-900. PMID 15328162 DOI: 10.1182/Blood-2002-08-2425 |
0.61 |
|
2003 |
Zhang Z, Cotta CV, Stephan RP, deGuzman CG, Klug CA. Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage. The Embo Journal. 22: 4759-69. PMID 12970188 DOI: 10.1093/Emboj/Cdg464 |
0.671 |
|
2003 |
Cotta CV, Zhang Z, Kim HG, Klug CA. Pax5 determines B- versus T-cell fate and does not block early myeloid-lineage development. Blood. 101: 4342-6. PMID 12560221 DOI: 10.1182/Blood-2002-10-3139 |
0.68 |
|
2002 |
Cotta CV, Weissman C, Weissman IL, Klug CA. Retroviral Transduction of FACS-Purified Hematopoietic Stem Cells. Methods in Molecular Medicine. 63: 243-52. PMID 21437812 DOI: 10.1385/1-59259-140-X:243 |
0.687 |
|
Show low-probability matches. |